Pineoblastoma - 50 Studies Found
Recruiting |
: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|
Completed |
: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma :
|
Recruiting |
: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors :
|
Completed |
: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors :
|
Active, not recruiting |
: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor :
|
Completed |
: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors :
|
Completed |
: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors :
|
Completed |
: Cilengitide in Treating Children With Refractory Primary Brain Tumors :
: |